Immunosuppressive Agents: all 5,940 studies that test it

Page 17 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.

• HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic MalignanciesCompletedNCT01119066Phase 2Results posted
• Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell TransplantTerminatedNCT01118013Phase 2Results posted
• A Cooperative Clinical Study of Abatacept in Multiple SclerosisCompletedNCT01116427Phase 2Results posted
• Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationTerminatedNCT01116232Phase 2Results posted
• Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant RecipientsCompletedNCT01114529Phase 3Results posted
• Everolimus Versus Placebo in Head and Neck CancerTerminatedNCT01111058Phase 2Results posted
• Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell CarcinomaCompletedNCT01108445Phase 2Results posted
• Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone SurgeryCompletedNCT01106898Phase 2Results posted
• Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)CompletedNCT01106833Phase 2/3Results posted
• Reversing Type 1 Diabetes After it is EstablishedCompletedNCT01106157Phase 1/2Results posted
• Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed EpendymomaCompletedNCT01096368Phase 3Results posted
• Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT01093586Phase 2Results posted
• Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate CancerTerminatedNCT01093183Phase 1/2Results posted
• Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic ArthritisCompletedNCT01087788Phase 3Results posted
• Certolizumab Pegol in Subjects With Active Axial SpondyloarthritisCompletedNCT01087762Phase 3Results posted
• Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)CompletedNCT01082939Phase 2Results posted
• Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease RecurrenceCompletedNCT01079988Phase 4Results posted
• Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant RecipientsCompletedNCT01079143Phase 3Results posted
• Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell TransplantTerminatedNCT01078441Phase 2Results posted
• Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaCompletedNCT01075321Phase 1/2Results posted
• Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain AmyloidosisCompletedNCT01072773Phase 2Results posted
• Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)CompletedNCT01070316Phase 1/2Results posted
• Letrozole and RAD001 With Advanced or Recurrent Endometrial CancerActive, not recruitingNCT01068249Phase 2Results posted
• Topical Cyclosporine Suspension for the Treatment of Brittle NailsCompletedNCT01064830Phase 2Results posted
• A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)CompletedNCT01063062Phase 3Results posted
• Calcineurin Inhibitor Sparing After Kidney TransplantationCompletedNCT01062555Phase 1/2Results posted
• Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT01062399Phase 1/2Results posted
• Thalidomide Low Threshold in EpilepsyCompletedNCT01061866Phase 1/2Results posted
• A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With LymphangioleiomyomatosisCompletedNCT01059318Phase 2Results posted
• RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal CancerCompletedNCT01058655Phase 1/2Results posted
• RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck CancerTerminatedNCT01057277Phase 1Results posted
• Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple MyelomaCompletedNCT01057225Phase 1/2Results posted
• Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's LymphomaCompletedNCT01055496Phase 1Results posted
• Can We Miss Pigmented Lesions in Psoriasis Patients?CompletedNCT01053819Phase 4Results posted
• Phase II Study of RAD001 Head and Neck CancerTerminatedNCT01051791Phase 2Results posted
• Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After DocetaxelCompletedNCT01051570Phase 2Results posted
• Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple SclerosisCompletedNCT01051349Phase 2Results posted
• Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cellsTerminatedNCT01050764Phase 1/2Results posted
• Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal SarcomasTerminatedNCT01048723Phase 2Results posted
• RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal CarcinomaCompletedNCT01047293Phase 1/2Results posted
• Allogeneic Bone Marrow Transplant for Inherited Metabolic DisordersCompletedNCT01043640Phase 2Results posted
• Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.CompletedNCT01035229Phase 3Results posted
• A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid ArthritisCompletedNCT01034137Phase 3Results posted
• Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCsCompletedNCT01033552Phase 1/2Results posted
• Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT01031446Phase 1/2Results posted
• Dose Dense MVAC for Muscle Invasive Bladder CancerCompletedNCT01031420Phase 2Results posted
• Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube CancerCompletedNCT01031381Phase 2Results posted
• Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTerminatedNCT01028716Phase 2Results posted
• Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01027000Phase 2Results posted
• Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant RecipientsCompletedNCT01025817Phase 3Results posted
• Desensitization With Belimumab in Sensitized Patients Awaiting Kidney TransplantTerminatedNCT01025193Phase 2Results posted
• Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict SensitivityCompletedNCT01024946Phase 2Results posted
• Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01024010Phase 2Results posted
• Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.CompletedNCT01023815Phase 3Results posted
• Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.CompletedNCT01022996Phase 2Results posted
• Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast CancerTerminatedNCT01022138Phase 2Results posted
• Everolimus in de Novo Heart Transplant RecipientsCompletedNCT01017029Phase 4Results posted
• Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus TumorsTerminatedNCT01014767Phase 3Results posted
• Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic MelanomaCompletedNCT01014351Phase 2Results posted
• Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCTCompletedNCT01012492Phase 2Results posted
• Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) LymphomaCompletedNCT01011920Phase 2Results posted
• Mismatched Transplantation Using High-dose Post-transplant CyclophosphamideCompletedNCT01010217Phase 2Results posted
• RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHNTerminatedNCT01009346Phase 1/2Results posted
• Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaCompletedNCT01008462Phase 2Results posted
• Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast CancerCompletedNCT01007942Phase 3Results posted
• A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid ArthritisCompletedNCT01007435Phase 3Results posted
• Sirolimus Conversions in African-American Renal Transplant RecipientsCompletedNCT01005706Not applicableResults posted
• Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)CompletedNCT01004432Phase 3Results posted
• The Efficacy and Safety of Adding Methotrexate to Etanercept in PsoriasisCompletedNCT01001208Phase 3Results posted
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateCompletedNCT01000610Phase 4Results posted
• Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal VaccinesCompletedNCT00993668Phase 4Results posted
• A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid ArthritisCompletedNCT00993317Phase 3Results posted
• Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast CancerCompletedNCT00992602Phase 2Results posted
• Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to EtanerceptCompletedNCT00992394Phase 4Results posted
• Study of Cyclosporine in Post-LASIK PatientsCompletedNCT00991458Phase 2Results posted
• Substudy - Low Dose of Abatacept in Subjects With Rheumatoid ArthritisCompletedNCT00989235Phase 3Results posted
• Long-term Topical Cyclosporine for Atopic KeratoconjunctivitisCompletedNCT00987467Not applicableResults posted
• Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach CancerCompletedNCT00985192Phase 2Results posted
• Drug-Drug Interaction Study Between Colchicine and CyclosporineCompletedNCT00983931Phase 1Results posted
• A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic EthnicityTerminatedNCT00983645Phase 4Results posted
• Tacrolimus Versus Prednisolone for the Treatment of Minimal Change DiseaseCompletedNCT00982072Phase 4Results posted
• Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LLTerminatedNCT00981799Phase 1/2Results posted
• Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent LymphomaCompletedNCT00980395Phase 2Results posted
• Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)TerminatedNCT00978432Phase 2Results posted
• Haploidentical PBMC Transplant for Severe Congenital AnemiasActive, not recruitingNCT00977691Phase 1/2Results posted
• Everolimus (RAD001) in Primary Therapy of Waldenstrom's MacroglobulinemiaCompletedNCT00976248Phase 2Results posted
• Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood CancerCompletedNCT00975975Phase 2Results posted
• Safety and Efficacy Study of Sirolimus in Complicated Vascular AnomaliesCompletedNCT00975819Phase 2Results posted
• Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)CompletedNCT00975130Phase 3Results posted
• Oral Cyclosporine in Chronic Obstructive Pulmonary DiseaseCompletedNCT00974142Phase 1/2Results posted
• Treatment of Older Adults With Acute Lymphoblastic LeukemiaCompletedNCT00973752Phase 2Results posted
• An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate TherapyCompletedNCT00973479Phase 3Results posted
• Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial MeningiomaTerminatedNCT00972335Phase 2Results posted
• Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor SyndromesCompletedNCT00971789Phase 2Results posted
• Low Dose Thymoglobulin to Protect Kidney Function After Liver TransplantCompletedNCT00970073Not applicableResults posted
• RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic LeukemiaCompletedNCT00968253Phase 1/2Results posted
• Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory LymphomaCompletedNCT00967044Phase 1/2Results posted
• Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT00966693Phase 1/2Results posted
• Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant RecipientsCompletedNCT00965094Phase 4Results posted
• Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular MalformationCompletedNCT00964496Phase 2Results posted

← Immunosuppressive Agents overview